Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pileri

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Hematological Oncology|January 6, 2021
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcomaMaria Rosaria Sapienza, Fabio Fuligni, Federica Melle, et al.
Annals of Hematology|April 18, 2026
Modern and multidisciplinary care in polycythemia veraFrancesca Palandri, Chiara Sartor, Alessandro Pileri, et al.
The American Journal of Surgical Pathology|March 27, 2024
Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid PapulosisErica Mark, Werner Kempf, Joan Guitart, et al.
Cancers|September 28, 2021
Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell NeoplasmMaria Rosaria Sapienza, Giuseppe Benvenuto, Manuela Ferracin, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood|February 2, 2008
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantageMarco Ladetto, Federica De Marco, Fabio Benedetti, et al.
Blood|August 15, 2002
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)Marco Ladetto, Paolo Corradini, Sonia Vallet, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Hematological Oncology|January 6, 2021
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcomaMaria Rosaria Sapienza, Fabio Fuligni, Federica Melle, et al.
Annals of Hematology|April 18, 2026
Modern and multidisciplinary care in polycythemia veraFrancesca Palandri, Chiara Sartor, Alessandro Pileri, et al.
The American Journal of Surgical Pathology|March 27, 2024
Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid PapulosisErica Mark, Werner Kempf, Joan Guitart, et al.
Cancers|September 28, 2021
Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell NeoplasmMaria Rosaria Sapienza, Giuseppe Benvenuto, Manuela Ferracin, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood|February 2, 2008
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantageMarco Ladetto, Federica De Marco, Fabio Benedetti, et al.
Blood|August 15, 2002
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)Marco Ladetto, Paolo Corradini, Sonia Vallet, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Pageof 17